Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism.

Schilbach K, Junnila RK, Bidlingmaier M.

Exp Clin Endocrinol Diabetes. 2018 Aug 30. doi: 10.1055/a-0672-0836. [Epub ahead of print]

PMID:
30165708
2.

Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults.

Ku CR, Brue T, Schilbach K, Ignatenko S, Magony S, Chung YS, Kim BJ, Hur KY, Kang HC, Kim JH, Kim MS, Kowalska A, Bolanowski M, Ruchala M, Damjanovic S, Payer J, Choi YJ, Heo SJ, Kim TK, Heo M, Lee J, Lee EJ.

Eur J Endocrinol. 2018 Sep;179(3):169-179. doi: 10.1530/EJE-18-0185. Epub 2018 Jul 4.

PMID:
29973375
3.

Biomarkers of GH action in children and adults.

Schilbach K, Olsson DS, Boguszewski MCS, Bidlingmaier M, Johannsson G, Jørgensen JL.

Growth Horm IGF Res. 2018 Jun;40:1-8. doi: 10.1016/j.ghir.2018.03.005. Epub 2018 Mar 20. Review.

PMID:
29601998
4.

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.

Johannsson G, Bidlingmaier M, Biller BMK, Boguszewski M, Casanueva FF, Chanson P, Clayton PE, Choong CS, Clemmons D, Dattani M, Frystyk J, Ho K, Hoffman AR, Horikawa R, Juul A, Kopchick JJ, Luo X, Neggers S, Netchine I, Olsson DS, Radovick S, Rosenfeld R, Ross RJ, Schilbach K, Solberg P, Strasburger C, Trainer P, Yuen KCJ, Wickstrom K, Jorgensen JOL; Growth Hormone Research Society.

Endocr Connect. 2018 Mar;7(3):R126-R134. doi: 10.1530/EC-18-0047. Epub 2018 Feb 26. Review.

5.

De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function.

Gebert D, Auer MK, Stieg MR, Freitag MT, Lahne M, Fuss J, Schilbach K, Schopohl J, Stalla GK, Kopczak A.

Psychoneuroendocrinology. 2018 Feb;88:61-69. doi: 10.1016/j.psyneuen.2017.11.006. Epub 2017 Nov 14.

PMID:
29175721
6.

IL-6/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis.

Theurich S, Tsaousidou E, Hanssen R, Lempradl AM, Mauer J, Timper K, Schilbach K, Folz-Donahue K, Heilinger C, Sexl V, Pospisilik JA, Wunderlich FT, Brüning JC.

Cell Metab. 2017 Jul 5;26(1):171-184.e6. doi: 10.1016/j.cmet.2017.05.018.

7.

Biochemical investigations in diagnosis and follow up of acromegaly.

Schilbach K, Strasburger CJ, Bidlingmaier M.

Pituitary. 2017 Feb;20(1):33-45. doi: 10.1007/s11102-017-0792-z. Review.

PMID:
28168377
8.

Update on the use of oral octreotide therapy for acromegaly.

Schilbach K, Schopohl J.

Expert Rev Endocrinol Metab. 2016 Jul;11(4):349-355. doi: 10.1080/17446651.2016.1199954. Epub 2016 Jun 29.

PMID:
30058923
9.

Growth hormone binding protein - physiological and analytical aspects.

Schilbach K, Bidlingmaier M.

Best Pract Res Clin Endocrinol Metab. 2015 Oct;29(5):671-83. doi: 10.1016/j.beem.2015.06.004. Epub 2015 Jun 27. Review.

PMID:
26522453
10.

Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.

Stöhr O, Schilbach K, Moll L, Hettich MM, Freude S, Wunderlich FT, Ernst M, Zemva J, Brüning JC, Krone W, Udelhoven M, Schubert M.

Age (Dordr). 2013 Feb;35(1):83-101. doi: 10.1007/s11357-011-9333-2. Epub 2011 Nov 6.

11.

Insulin receptor substrate-1 and -2 mediate resistance to glucose-induced caspase-3 activation in human neuroblastoma cells.

Stöhr O, Hahn J, Moll L, Leeser U, Freude S, Bernard C, Schilbach K, Markl A, Udelhoven M, Krone W, Schubert M.

Biochim Biophys Acta. 2011 May;1812(5):573-80. doi: 10.1016/j.bbadis.2011.02.006. Epub 2011 Feb 24.

12.

IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.

Freude S, Leeser U, Müller M, Hettich MM, Udelhoven M, Schilbach K, Tobe K, Kadowaki T, Köhler C, Schröder H, Krone W, Brüning JC, Schubert M.

J Neurochem. 2008 Nov;107(4):907-17. doi: 10.1111/j.1471-4159.2008.05631.x. Epub 2008 Sep 18.

Supplemental Content

Loading ...
Support Center